Christina Y Weng, MD, MBA sat down to discuss the Retina Ophthalmic Technology Assessment Symposium and her journal on ...

Regeneron (REGN) announced three-year data for EYLEA HD Injection 8 mg from an extension study of the Phase 3 PHOTON trial in ...

According to data presented in a late-breaking oral presentation at the American Academy of Ophthalmology 2024 Annual Meeting ...

Regeneron Pharmaceuticals Inc. (REGN) announced positive three-year (156-week) data for EYLEA HD (aflibercept) Injection 8 mg from an ...

Roche (RHHBY) announced positive topline one-year results from the open-label, single-arm phase IV ELEVATUM study evaluating Vabysmo ...

The ELEVATUM study showed clinically meaningful improvement in vision and reduction in retinal fluid in people with diabetic ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline one-year results from ...

Says APC creating division in opposition to retain power in 2027•PDP, NNPP mulls alliance to sack APC By Dayo Johnson The New ...

President Bola Tinubu has again been sent a packing warning as NNPP revealed dangerous permutations ahead of the 2027 ...

So yes, we should strive for diversity in our medical work force. Indeed, medical schools in Canada already factor in ...

He said: “The mantra of the NNPP is education for all. As a party, education is key in whatever we are doing. Come September 2025, there shall be no tuition in all our schools. We are declaring free ...

The most pressing challenges include the financial and emotional burdens associated with frequent, long-term treatments for ...